nordic

Correction: Resolutions of the Annual General Meeting 2025 of Bavarian Nordic A/SCorrection: Resolutions of the Annual General Meeting 2025 of Bavarian Nordic A/S

Correction: Resolutions of the Annual General Meeting 2025 of Bavarian Nordic A/S

COPENHAGEN, Denmark, April 9, 2025 – Bavarian Nordic A/S (OMX: BAVA) today held the Annual General Meeting with the following…

3 weeks ago
Resolutions of the Annual General Meeting 2025 of Bavarian Nordic A/SResolutions of the Annual General Meeting 2025 of Bavarian Nordic A/S

Resolutions of the Annual General Meeting 2025 of Bavarian Nordic A/S

COPENHAGEN, Denmark, April 9, 2025 – Bavarian Nordic A/S (OMX: BAVA) today held the Annual General Meeting with the following…

3 weeks ago

Athletes hail Para integration at Nordic World Ski Championships Trondheim 2025, but hint at room for improvement

Apr 01, 2025 - One of the highlights of the FIS Nordic World Ski Championships Trondheim 2025 was the integration…

1 month ago
EDGNEX Data Centers by DAMAC Confirms Strategic Partnership with Nordic Data Center Developer HypercoEDGNEX Data Centers by DAMAC Confirms Strategic Partnership with Nordic Data Center Developer Hyperco

EDGNEX Data Centers by DAMAC Confirms Strategic Partnership with Nordic Data Center Developer Hyperco

New acquisition in Nordics is part of the company's ambitious European and global expansion plan.The acquisition is expected to strengthen the…

1 month ago

More races, more excitement for Nordic Combined fans at Trondheim 2025 WSC

Mar 18, 2025 - Among the success stories of the Trondheim 2025 Nordic World Ski Championships (WSC) was the addition…

2 months ago
Bavarian Nordic Receives U.S. FDA Approval of Chikungunya Vaccine for Persons Aged 12 and OlderBavarian Nordic Receives U.S. FDA Approval of Chikungunya Vaccine for Persons Aged 12 and Older

Bavarian Nordic Receives U.S. FDA Approval of Chikungunya Vaccine for Persons Aged 12 and Older

First chikungunya vaccine approved for persons as young as 12 years old, addressing an unmet need for chikungunya prevention for…

3 months ago
Bavarian Nordic Completion of Share Buy-Back ProgramBavarian Nordic Completion of Share Buy-Back Program

Bavarian Nordic Completion of Share Buy-Back Program

COPENHAGEN, Denmark, January 31, 2025 – Bavarian Nordic A/S (OMX: BAVA) announces that the share buy-back program, which was announced…

3 months ago
Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with suchReport of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such

Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such

COPENHAGEN, Denmark, November 29, 2024 – Bavarian Nordic A/S (OMX: BAVA) has today received information about the following transactions of…

5 months ago
Bavarian Nordic Announces Interim Results for the First Nine Months of 2024Bavarian Nordic Announces Interim Results for the First Nine Months of 2024

Bavarian Nordic Announces Interim Results for the First Nine Months of 2024

COPENHAGEN, Denmark, November 15, 2024 – Bavarian Nordic A/S (OMX: BAVA) announced today its interim financial results for the first…

6 months ago
Nordic Bioscience receives Letter of Support from the FDA for the CPa9-HNE biomarker in inflammatory bowel diseasesNordic Bioscience receives Letter of Support from the FDA for the CPa9-HNE biomarker in inflammatory bowel diseases

Nordic Bioscience receives Letter of Support from the FDA for the CPa9-HNE biomarker in inflammatory bowel diseases

HERLEV, Denmark, Nov. 11, 2024 /PRNewswire/ -- Nordic Bioscience, a leading biomarker company, announced that its CPa9-HNE biomarker assay received a…

6 months ago